The Michael J. Fox Foundation covers all aspects of therapeutic development both to directly support individual projects with great potential to help people with Parkinson’s and to provide the field with tools applicable across targets and projects.
For example, the Foundation funds projects that: screen and optimize compounds; test drug and non-pharmacological interventions in clinical trials; identify and validate biomarkers and predictive models to inform subject selection, monitor disease and measure therapeutic impact and gather patient-reported outcomes to enrich study design.
As the world's largest non-profit funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers.
In addition to funding more than $900 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges ground-breaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.
MassBio’s mission is to advance Massachusetts’ leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing 1,200+ biotechnology companies, academic institutions, disease foundations and other organizations involved in life sciences and healthcare, MassBio leverages its unparalleled network of innovative companies and industry thought leaders to advance policy and promote education, while providing member programs, events, industry information, and services. Learn more at www.MassBio.org.
A non-profit organization with the goal to facilitate and accelerate the research to find prevention and treatment therapeutics for Alzheimer’s disease, and to provide services and support to our stakeholders around the world.